Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst
26/5 04:02
5 Space Stocks That Could Soar in the Next DecadeOpus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr...